Protalix BioTherapeutics, Inc. — insider transactions
8 transactions on record · CIK 1006281
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
8
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
4
Bought, 3m
$0
Sold, 3m
$0
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
—
Director share, 12m
100.0%
of transactions where role is stated
Current run
8 sells
consecutive same-direction transactions
Net 3m flow
$0
purchases minus sales
Total on record
8
Transactions
8 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-04 | 2026-09-03 | 1 | Bar-Shalev Amos | Director | Grant or award | 17,000 | $0.00 | — | filing |
| 2026-09-04 | 2026-09-03 | 1 | Ben Zvi Shmuel | Director | Grant or award | 8,500 | $0.00 | — | filing |
| 2026-09-04 | 2026-09-03 | 1 | Bar-Shalev Amos | Director | Grant or award | 8,500 | $0.00 | — | filing |
| 2026-09-04 | 2026-09-03 | 1 | Bashan Dror | Director, PRESIDENT AND CEO | Grant or award | 160,000 | $0.00 | — | filing |
| 2026-09-04 | 2026-09-03 | 1 | Ben Zvi Shmuel | Director | Grant or award | 17,000 | $0.00 | — | filing |
| 2026-09-04 | 2026-09-03 | 1 | Bashan Dror | Director, PRESIDENT AND CEO | Grant or award | 320,000 | $0.00 | — | filing |
| 2026-09-04 | 2026-09-03 | 1 | Boudes Pol F | Director | Grant or award | 8,500 | $0.00 | — | filing |
| 2026-09-04 | 2026-09-03 | 1 | Boudes Pol F | Director | Grant or award | 17,000 | $0.00 | — | filing |